CTS Ceretas Limited
Ceretas Limited, a medical technology company that develops portable and non-invasive therapeutic ultrasound platform for the treatment of Alzheimer's disease and other neurodegenerative conditions in Australia. The company's technology operates through two primary mechanisms, including neuromodulation, which uses low-intensity focused ultrasound to stimulate neural circuits; and BBBO, which temporarily and reversibly opens the blood-brain barrier using ultrasound combined with circulating microbubbles that facilitates brain's natural clearance of amyloid-beta and tau and helps delivery of co-administered drugs to targeted brain regions. Ceretas Limited was incorporated in 2024 and is based in Brisbane, Australia.
Returns
| 1 day | 2.9% |
| 1 week | -5.8% |
| 1 month | -15.6% |
| 3 months | — |
| 6 months | — |
| 1 year | — |
| 3 years | — |
Risk
| Volatility (1y ann.) | 87.0% |
| Beta vs ASX 200 | — |
| Sharpe (1y) | 2.82 |
| VaR 95% (1-day) | -7.4% |
| Max drawdown (1y) | -19.9% |
| Off 1-year high | -17.6% |
Technicals
| RSI(14) | 40 |
| vs 50DMA | 9.0% |
| vs 200DMA | — |
| Trend | — |
Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).